➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Colorcon
Johnson and Johnson
Mallinckrodt
McKesson

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Details for Patent: 10,076,494


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,076,494
Title:Stable orally disintegrating pharmaceutical compositions
Abstract: Described herein are stable orally disintegrating tablets containing a proton pump inhibitor, methods for making the same, and methods for treating subjects in need thereof. In particular, the orally disintegrating tablets are composed of a plurality of coated units admixed with a disintegrant that demonstrate decreased friability and increased hardness.
Inventor(s): Pevzner; Victor (Hadera, IL), Moses-Heller; Sheera (Atlit, IL)
Assignee: DEXCEL PHARMA TECHNOLOGIES LTD. (Or-Akiva, IL)
Application Number:15/372,917
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Dosage form;

Drugs Protected by US Patent 10,076,494

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dexcel Pharma ESOMEPRAZOLE MAGNESIUM esomeprazole magnesium TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 214278-001 Oct 20, 2020 OTC Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
Dexcel Pharma OMEPRAZOLE omeprazole TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL 209400-001 Jul 5, 2017 OTC Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,076,494

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2017285390 ⤷  Free Forever Trial
European Patent Office 3471708 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 2017216789 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Harvard Business School
McKinsey
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.